Label Value
DOI 10.1186/s12885-018-4001-x
TITLE The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
TYPE article
Service Status Date Last Checked
Scopus Yes 2018-02-16T03:30:26.864289
Web of Science Yes 2018-04-08T03:14:57.904887
Compendex No 2019-12-18T12:58:41.195699